Key points are not available for this paper at this time.
Figure S6 shows SpiD3 inhibits NF-κB activity and diminishes CD40L-induced survival signaling in CLL.
Share your take
Add a clinician perspective alongside expert commentary.
Eiken et al. (2024) studied this question.